“Global Supply Chain Visibility and Security; Business Necessity, Regulatory Imperative”

Share Article

Axendia Launches Life Sciences Research Study

In light of recent adverse events, Industry and Regulators are preparing to take significant steps to secure the Life Science Global Supply Chain.

The globalization of manufacturing and supply of medical products has created unique and demanding challenges for the Life Sciences industry and the U.S. Food and Drug Administration alike. In light of recent adverse events, Industry and regulators are preparing to take significant steps to secure the Global Supply Chain. Axendia, Inc., today announced that it has launched a research study entitled, “Global Supply Chain Visibility and Security; Business Necessity, Regulatory Imperative”.

This research seeks to identify and analyze trends, requirements, and initiatives Life-Science companies are undertaking to gain deeper visibility and controls over Global Supply and Value Chains.

The study will focus on:
    -Assessing current and desired states of Life Science supply chains
    -Identifying key challenges facing global and outsourced ecosystems
    -Outlining innovative strategies and system to enable and guide this transformation
    -Provide a roadmap to achieve Global Supply Chain Visibility and Security

Axendia researchers will seek insight from industry leaders and regulators on innovative strategies and technologies, enabling supply chain visibility and security, risk mitigate, and increased business success.

This research study is co-sponsored by leading companies active in the Life Sciences sector, including (in alphabetical order): Camstar Systems (http://www.camstar.com) and IBM (http://www.ibm.com). These companies are working to increase the understanding of processes and systems that support global visibility and transparency across the Life Sciences value chain.

The results of this study will be presented in a report detailing current and best practices in Global Supply Chain Visibility and Security in Life Sciences. The research report will include tables and charts supporting research findings. Axendia will conduct the study research, analysis and report, and retain full editorial control.

About Axendia, Inc.
Axendia is a leading analyst and strategic advisory firm focused on the Life Sciences and Healthcare markets. We provide trusted advice to industry Executives on Business, Regulatory, and Technology issues. Axendia professionals offer a unique combination of deep hands-on industry experience coupled with strategic vision.

Axendia serves the complete Life Science Ecosystem including Industry Organizations, Technology & Service Providers and the Investment community. Our clients range from startups to Fortune 100 companies. We contribute to our client’s success by providing long-range visibility and helping them navigate the ever-changing landscape in the Life Sciences and Healthcare markets.

For more information, visit http://www.axendia.com or contact us at info(at)axendia(dot)com , read Axendia’s blog: Life-Science Panorama at http://LSP.axendia.com or follow us on Twitter at http://twitter.com/axendia

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lisa George
Visit website